Compare NTR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTR | GEHC |
|---|---|---|
| Founded | 2017 | 1892 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9B | 35.8B |
| IPO Year | 2018 | 2022 |
| Metric | NTR | GEHC |
|---|---|---|
| Price | $71.61 | $84.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 18 | 12 |
| Target Price | $66.83 | ★ $91.17 |
| AVG Volume (30 Days) | 2.5M | ★ 3.2M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 3.04% | 0.17% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $6.22 | $7.15 |
| Revenue Next Year | $1.44 | $4.53 |
| P/E Ratio | $18.99 | ★ $18.22 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $45.78 | $57.65 |
| 52 Week High | $73.55 | $92.20 |
| Indicator | NTR | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 63.14 |
| Support Level | $69.41 | $76.66 |
| Resistance Level | $73.55 | $83.18 |
| Average True Range (ATR) | 1.86 | 2.66 |
| MACD | -0.19 | 0.61 |
| Stochastic Oscillator | 69.56 | 99.44 |
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).